Gastro Education 2018
Journal of Clinical Gastroenterology and Hepatology
ISSN: 2575-7733
Page 62
September 06-07, 2018
London, UK
14
th
International Conference on
Gastro Education
S
ince the dawn of the Post-Genomic era (25 years back),
applying a genetic approach to solving various intricate
problems/issues in research has taken-off even more swiftly
than ever before. Spatio-temporal cues defined for certain critical
components in a particular developmental pathway (involved in
causing/progression of certain disease) provide a firm basis for
detecting the order, hierarchy and “switching-off or on” of genes
that regulate it. The various time-points, at which genes are
switched on/off, clearly determines the fate of what a cell does
in terms of being functional or non-functional, due to disruption
of that specific pathway. Recent research-work in this area
(Bhojwani, 2015) provides strong evidence, toward identifying
such components (associated with Wnt-signaling involved in
Colorectal Cancer-CRC disease). These crucial elements indeed
determined the genetic transformation of a “blank-slate” (“cells
of origin” and/or putative “cancer stem cells”) or “primitive-state”
epithelial cells to an intermediate adenoma/polyp (dyspastic),
and later to a proliferative (hyperplastic) or cancerous (neoplastic)
state. The idea is to re-iterate the power of genetics, in solving and
filling the missing links of any developmental pathway involved in
progression of a disease (in this case, CRC). A critical temporal
requirement of certain molecules [Caesin-Kinase I (CKI) and
Human-Discs-large (hDlg)] was finally established and these
proteins were identified as “early” and “late” acting molecules
respectively, in a very crucial developmental event, that basically
transforms “polyps” to full-fledged “carcinomas” (epithelial
cancers) in COLORECTAL tumors. The detection of these genetic
and developmental parameters, served as a focal-point and a
prominent diagnostic feature, for detection of effects, ie. gain/
loss of other components involved during progression of CRC
disease. Coincidentally, the chromosomes on which these genes
reside have been found to be dense and rich in SNPs (hot-spots),
the details of which were published in a separate report (Patidar
& Bhojwani, 2013). This work harnessed the potential of Genetics,
Developmental Biology and Bio-Informatics tools to solve a long-
standing puzzle in pin-pointing some genetic factors that were
critically involved in the progression of CRC disease. The report
has created enough impact, in terms of authentically suggesting,
that it is only when we deploy a combinatorial approach towards
certain complicated biological problems, can we successfully
unveil the underlying mechanisms in greater details. However, it
is now conceived that, at the heart of every tumor lies a rare sub-
population of cells (Cancer Stem Cells-CSCs), which give rise to
most of theCancersandarenowthe targetsof investigation. Since
no definitive markers or efficient labeling tools are available, this
population of cells still remains elusive in both cancer and stem
cell biology. Therefore, it would be critical to understandmolecular
differences between stem cells and cancer cells, which might
be helpful in providing novel insights into the mechanism
of tumorigenesis as well as potential therapeutic targets, in
foreseeable future. We have come a long way in the stem cell
advances over time. Very recent breakthroughs include: (a) The
tuning and genetic re-programming of stem cells (iPS cells) by a
handful of genetic factors (Takahashi et al, 2006, 2007; discussed
in Bhojwani, 2008) and; (b) The transformation of cancerous cells
to normal cells by reversing the genetic changes involved and
also restricting the awry cancerous cells by using microRNAs
(http://yournewswire.com/breakthrough-scientists-find-way-to-change-cancer-cells-into-healthy-cells/). My talk would shed light
on how we could intelligently utilize these efficient tools together,
to attack the “Bad seeds” in ways to cure the myriad diseases,
like Cancer.
jbhojwani2005@gmail.comImpact of deploying a genetic approach to stem cells opens-up
new facets in the blank slates of our body
Jyoti Bhojwani
DAVV, India
J Clin Gastroenterol Hepatol 2018, Volume 2
DOI: 10.21767/2575-7733-C2-006




